OpenAlex
PricingAboutJobs
Log inGet started
Work

Nuclear morphometry as an intermediate endpoint biomarker in chemoprevention of cervical carcinoma using ?-difluoromethylornithine

HTML

Year: 1999
Type: article
Study design: Clinical Trial
Source: Cytometry
DOI: 10.1002/(sici)1097-0320(19991015)38:5<214::aid-cyto3>3.0.co;2-6
Authors: Neal Poulin, Iouri Boiko, Calum MacAulay, Charles Boone, Kenji Nishioka, Walter Hittelman, Michele Follen Mitchell
Institutions: BC Cancer Agency, The University of Texas MD Anderson Cancer Center, National Cancer Institute
Language: English

Topic: Cervical Cancer and HPV Research
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Keywords: nuclear morphometry, difluoromethylornithine, cervical intraepithelial neoplasia, CIN III, nuclear atypia, treatment response prediction, histopathology
SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute
Awards: G604892751, PHASE II CLINICAL TRIALS OF N-(4-HYDROXYPHENYL), G797002893
OpenAlex ID: W1981707099
FWCI: 1.067
Cites: 32
Cited by: 17
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security